Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation

被引:30
作者
Shirabe, K. [1 ]
Aishima, S. [2 ]
Taketomi, A.
Soejima, Y.
Uchiyama, H.
Kayashima, H.
Ninomiya, M.
Mano, Y. [2 ]
Maehara, Y.
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan
关键词
GAMMA-CARBOXY PROTHROMBIN; EARLY RECURRENCE; RISK-FACTORS; TUMOR SIZE; EXPRESSION; RESECTION; INVASION; IMPACT;
D O I
10.1002/bjs.7311
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The gross classification of hepatocellular carcinoma (HCC) has been reported to be a significant prognostic factor for patients with HCC undergoing partial hepatectomy. The present study investigated whether the gross classification of HCC is also a prognostic factor in living donor-related liver transplantation (LDLT). Methods: Some 119 patients undergoing LDLT for HCC were identified retrospectively from a prospective institutional database containing information on all LDLTs carried out between 1996 and 2009. Patients were divided into three groups according to the gross classification of the largest tumour in the explanted liver: type 1 HCC, single nodular type (81 patients); type 2, single nodular type with extranodular growth (21); and type 3, contiguous multinodular type (17). Clinicopathological factors and recurrence-free survival rates were compared. Results: Recurrence-free survival rates for the whole group were 87.7 per cent at 1 year, 83.5 per cent at 3 years and 81.0 per cent at 5 years after LDLT. Type 3 HCC was associated with large tumour size, poor histological grade, a high incidence of microvascular invasion and multiple tumours. Independent predictors of poor recurrence-free survival were preoperative serum level of des-gamma-carboxy prothrombin exceeding 300 mAU/ml, microvascular invasion and type 3 HCC. Conclusion: The gross classification of HCC was an independent predictor for recurrence of HCC in patients undergoing LDLT.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 26 条
  • [21] Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
    Sumie, Shuji
    Kuromatsu, Ryoko
    Okuda, Koji
    Ando, Eiji
    Takata, Akio
    Fukushima, Nobuyoshi
    Watanabe, Yasutomo
    Kojiro, Masamichi
    Sata, Michio
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (05) : 1375 - 1382
  • [22] Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
    Taketomi, Akinobu
    Sanefuji, Kensaku
    Soejima, Yuji
    Yoshizumi, Tomoharu
    Uhciyama, Hideaki
    Ikegami, Toru
    Harada, Noboru
    Yamashita, Yoichi
    Sugimachi, Keishi
    Kayashima, Hiroto
    Iguchi, Tomohiro
    Maehara, Yoshihko
    [J]. TRANSPLANTATION, 2009, 87 (04) : 531 - 537
  • [23] *UN NETW ORG SHAR, POL 3 6
  • [24] Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
    Yao, FY
    Ferrell, L
    Bass, NM
    Watson, JJ
    Bacchetti, P
    Venook, A
    Ascher, NL
    Roberts, JP
    [J]. HEPATOLOGY, 2001, 33 (06) : 1394 - 1403
  • [25] YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO
  • [26] 2-A